
A Derm's Guide to Simplifying Your Skin-Care Routine Without Sacrificing Results
The more work you put into something, the better the outcome, right? Actually, it's not always so when it comes to your skin-care routine. While there's nothing wrong with using double digits' worth of products if you really want to, you can achieve results with much less time, effort, and counter real estate, according to Dr. Hadley King, a New York City-based board-certified dermatologist. It's all about identifying your main skin goals, and then choosing products with formulas that work harder for your needs.
'Skin minimalism doesn't mean that you're choosing just one ingredient to use, or a single skin concern to focus on,' Dr. King says. 'Well-formulated products smartly incorporate multiple ingredients in one—so you don't need to use 10 products to reap major benefits.'
Here, the derm shares her top tips for building an efficient, results-driven routine, as well as why Rodan + Fields is her recommended brand to do it with.
Take the guesswork out of the equation. Dr. King is a fan of Rodan + Fields because the female-founded brand offers dermatologist-developed regimens created for different skin concerns, each with three to four complete steps. 'So much thought has been put into the ingredient combinations in each formula, and the products are engineered to work together,' she says. The options include Redefine, an anti-aging system that lifts, firms, and visibly minimizes the appearance of lines; Unblemish, which works to clear and prevent breakouts as well as to visibly minimize the look of pores and fine lines; and Reverse, designed to target discoloration and dark spots at every step.
If you're struggling with where in your routine you can downsize, Dr. King suggests wiping the slate clean and going back to the essentials. 'The basics are always going to be a gentle cleanser, a moisturizer, and SPF that all support the skin barrier,' she says. This simple combination is key in addressing so many skin concerns, from dehydration and sensitivity to signs of aging and skin-cancer prevention.
This step is where your skin's unique needs really take center stage. Once you've built a solid base, consider your most pressing concerns—acne, wrinkles, dullness—and then look for a treatment product with active ingredients that are proven to target them, such as a concentrated serum.
To effectively tackle adult acne, for example, Dr. King recommends Rodan + Fields Unblemish Dual Intensive Acne Treatment, which you can purchase solo or as part of the Unblemish Regimen. 'As you get older, you need to be cautious to choose acne products your skin can tolerate,' she says, noting that harsh formulas that work on teen skin can be too irritating for adults. In addition to 2.5 percent benzoyl peroxide to clear and prevent blemishes, the multitasking Unblemish treatment also contains pomegranate and chamomile extracts to calm redness, and ceramides to condition, hydrate, and visibly plump.
Or to target multiple signs of aging in one step, look for a serum with proven ingredients that firm, boost cell turnover, hydrate, and defend against the environmental aggressors that cause these concerns—like Rodan + Fields Total RF Serum. It features the brand's patented RF TriEnergy Complex, which revitalizes compromised skin cells for a more youthful appearance, and also works to address uneven tone and texture, dullness, dry skin, and enlarged pores.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
CSI Pharmacy Secures California Non-Resident Permit, Achieving Nationwide Reach
Bringing Personalized Specialty Pharmacy Services to All 50 States NASHVILLE, Tenn., June 4, 2025 /PRNewswire/ -- CSI Pharmacy is proud to reveal that, as of May 13, 2025, it is officially licensed to serve patients in all 50 states with the approval of two non-resident California pharmacy permits. This milestone marks a major achievement in CSI Pharmacy's mission to deliver personalized, patient-centered specialty pharmacy care to individuals living with chronic and rare diseases. James Sheets, PharmD, CEO and Founder of CSI Pharmacy, shared his thoughts on the significance of this expansion: "Reaching all 50 states is more than a milestone for us — it's a reflection of our commitment to ensure patients receive the highest level of care and comfort. California is home to one of the most diverse patient populations in the country, and we're excited to deliver our compassionate, personalized care to communities that need it most. At CSI, we believe in 'individualized therapies designed to be as unique as you,' and we're proud to extend that promise to every corner of the nation." With licensure secured, CSI Pharmacy can begin serving California-based patients immediately. Several patient transfers are already in progress, and their team is prepared to onboard additional referrals. To meet growing demand, CSI Pharmacy will expand its team to support this new territory in the coming months. Additionally, CSI Pharmacy is exploring physical space options in the state as well. While this physical location is not required to serve patients, the future brick and mortar expansion represents the passion they hold to serve patients well and quickly. The new licenses not only emphasize CSI Pharmacy's nationwide capabilities, but it also highlights an ongoing commitment to access, equity, and personalized care across every community CSI Pharmacy serves. About CSI PharmacyCSI Pharmacy is a nationwide specialty infusion pharmacy focused on supporting patients with chronic and rare conditions through home-based immunoglobulin (IVIg and SCIg) therapies and other complex medications. The expert team works closely with providers, insurance groups, and advocacy organizations to ensure timely access to life-changing treatments with compassion, precision, and purpose. For more information, visit or contact info@ View original content to download multimedia: SOURCE CSI Pharmacy
Yahoo
2 hours ago
- Yahoo
DIA 2025 Global Annual Meeting Spotlights FDA Leadership with Opening Plenary, FDA Town Hall, and Global Regulatory Delegations
FDA Commissioner Dr. Martin A. Makary to join EMA, MHRA, and AAAS leadership for Opening Plenary; FDA Town Hall to feature moderated discussion with agency leadership on current regulatory priorities WASHINGTON, May 28, 2025--(BUSINESS WIRE)--DIA, a global non-profit organization of life sciences professionals, will convene the world's leading regulators, researchers, and innovators from nearly 50 countries at the DIA 2025 Global Annual Meeting, held June 15–19 in Washington. As the life sciences industry confronts rapid scientific advances and shifting global health policies, the Global Annual Meeting offers an opportunity for stakeholders to align in real time on regulation, innovation, and global access. This year's program will feature more than 200 sessions across 12 content tracks, including insights from 35 U.S. Food and Drug Administration (FDA) speakers and 103 confirmed participants from global regulatory agencies. The event's emphasis on transparency and cross-border collaboration reflects growing demand for unity amid fragmented global health systems. At the forefront of this year's agenda is FDA Commissioner Dr. Martin A. Makary, who will share insights on Monday, June 16, during the conference's Opening Plenary. Dr. Makary will be joined by Emer Cooke, Executive Director of the European Medicines Agency (EMA) and Chair of the International Coalition of Medicines Regulatory Authorities (ICMRA), who will be honored among the Fellows of DIA and recipients of the Global Inspire Awards; Lawrence Tallon, Chief Executive Officer of the UK's Medicines and Healthcare products Regulatory Agency (MHRA); and Dr. Sudip Parikh, Chief Executive Officer of the American Association for the Advancement of Science (AAAS). Keynote speakers Jimi Olaghere, a sickle cell disease advocate whose experience receiving CRISPR-based gene therapy marks a milestone in patient-led innovation, and Dr. Doug Melton, a distinguished research fellow at Vertex Pharmaceuticals known for his pioneering work in stem cell biology, will also participate in the Opening Plenary, addressing regulatory cooperation, public trust, and the path forward for global innovation. "Global progress depends on shared priorities, open access, and evidence-based policy," said Marwan Fathallah, DIA's President and Global Chief Executive. "DIA's Global Annual Meeting offers a rare opportunity to hear directly from regulators on the front lines of policy and innovation — and to confront the challenges affecting patients worldwide." Also on the agenda is the FDA Town Hall, a moderated forum that invites attendees to engage directly with FDA leadership on the agency's current regulatory priorities. The session, scheduled for Thursday, June 19, will offer attendees the opportunity to submit questions for open discussion. Starting the week with star power and inspiration, Grammy-nominated artist and songwriter Aloe Blacc is set to perform at both the DIA Inspire Awards and the Planet Word Networking Reception. Renowned physician and global health leader, best known for his pivotal role in the eradication of smallpox, Dr. Larry Brilliant will also speak at the Inspire Awards on June 15. Tickets for the Inspire Awards ceremony are available to the public for the first time and can be purchased here. You can also purchase tickets for the Planet Word Networking Reception here. To register for the DIA 2025 Global Annual Meeting or view the full event program, visit Members of the media may request credentials by emailing diaglobal@ About DIA DIA is a leading global non-profit life science membership association that drives collaboration in drug, device, and diagnostics development in pursuit of a healthier world. Founded in 1964 with headquarters in Washington, D.C., and offices in Europe and Asia, DIA provides unparalleled networking opportunities, educational resources, scientific research publications, and professional development programs to members in more than 80 countries. Learn more at and connect with DIA on LinkedIn, Facebook, X (Twitter), and Instagram. View source version on Contacts Media Contacts Katie KennedyGregory FCAdiaglobal@ 610-731-1045 Kali GillGregory FCAdiaglobal@ 610-731-4179 Sign in to access your portfolio
Yahoo
2 hours ago
- Yahoo
British surgeon volunteering in Gaza hospital details 'dire situation'
This is not the first time Dr. Victoria Rose has visited the war-ravaged Gaza Strip, but she said the current situation on the ground is the worst she's ever seen it. Rose, a London-based consultant plastic surgeon, has been volunteering in weekslong stints at Gaza hospitals since the ongoing Israel-Hamas war erupted in October 2023. Most recently, she spent the month of May operating on the wounded at Nasser Medical Complex in Khan Younis, the largest referral hospital -- and now the only one still functioning -- in southern Gaza. "I think it's mainly the volume of patients that are coming in now. When we were here in August, we were seeing a lot of bomb victims, but not as many as we're seeing now," Rose told ABC News during an interview at the hospital on Saturday. "We are seeing patients, we're getting them on the operating table, we are cleaning the wounds and we are making a plan for their reconstruction," she added. "And then we're sending them back to the ward and then we're not getting a chance to get them back and do the reconstruction because so many more new bomb injuries come in and then we start again. So it's very difficult to keep up with this ongoing workload that's coming through the door." Rose said Israeli forces have been relentlessly bombing the area in recent weeks and, as a result, Nasser Medical Complex has seen a surge in patients. ABC News was allowed into the hospital's operating room as Rose performed extensive surgery on an 18-year-old patient, who she said "had quite a significant injury to his right arm" from a blast. "If they just stop bombing us for a couple of days, it would mean that we could catch up with the backload," Rose said. "I woke up this morning at 2 a.m. to nonstop bombing and all I could think about is the number of patients that that's going to bring through the door that we can't cope with here." The Israel Defense Forces launched an extensive new ground operation in Gaza last month targeting Hamas militants and what it called "terrorist infrastructure sites above and below ground." At least 54,381 people in Gaza have been killed and 124,054 have been wounded, according to the Hamas-run Gaza Ministry of Health, since the war began after Hamas attacked Israel on Oct. 7, 2023, killing 1,200 people and taking hundreds hostage. At least 20 hostages remain in Hamas captivity. Bed occupancy at Nasser Medical Complex is currently over 100%, while 47% of essential drugs are out of stock at the hospital along with 65% of all consumable items, according to Rose. "So we really are on our knees at the moment. We don't have anything," she told ABC News. "And on top of that, we have a really, really depleted health care staff." "We've lost a lot of them because they've been displaced and they've had to move, so they can't get to the hospital," she continued. "We've a lost a lot them because they have been detained or they've left Gaza. The staff that we have are tired. They've been working nonstop since the war started. So it's a really difficult situation all around." The hospital is located about a mile from where active fighting is currently taking place between Israeli forces and Hamas militants, according to Rose, who fears that Israeli troops will "encircle us" and "cut us off completely" rather than evacuate the complex. "So it's a really dire situation because if Nasser goes out of function, all of the patients that you see here on the ICU department will die -- and this is one of three ICUs that we have at Nasser," Rose said, referring to the critically ill patients lying in beds behind her. "Plus, the fact that none of the other hospitals around us -- even combined -- could take the number of patients that we have here." Rose said she's also seen the effects of malnutrition on the civilian population, particularly children, after Israel's 11-week blockade on all food and other essential supplies entering Gaza. Since May 19, Israel has allowed a limited amount of humanitarian aid into the Hamas-governed Palestinian territory, but the United Nations and other organizations have repeatedly warned it's far from enough and that famine is imminent. "We have had a patient in our operating theater where we've had to cancel the procedure because he was so malnourished and we didn't feel that he would survive the surgery," Rose told ABC News. "The other thing that we are noticing is that people are not able to heal their wounds as effectively as they should do. So because of the malnutrition, they're not getting the essential nutrients and vitamins they need." Cell turnover -- the process of producing new skin cells -- "is poor, so they're not healing," Rose said. She added, "Coupled with that, there's a massive spike in infection this time compared to when we were here in August. Everybody's wounds get infected and that's a real sign of malnutrition." ABC News' Helena Skinner contributed to this report.